Search Videos and More
Diagnosing the Apical Variant of Hypertrophic Cardiomyopathy
A 60-year-old man with a history of hypertension was admitted to the hospital after three days of a drooping face and right arm weakness. He had no chest pain or shortness of breath, and no prior history of irregular heartbeat. However, his echocardiogram was abnormal, and his high sensitivity troponin level was mildly to moderately elevated. Doctors ordered STAT echocardiogram with saline contrast, but the initial images were perplexing – normal left ventricle function, no evidence of systolic anterior motion, and nothing to suggest an LVOT obstruction.Breaking Down Updated Aortic Guidelines for Echocardiographers
In 2022, the American College of Cardiology and the American Heart Association released updated aortic guidelines that synthesized some 20 separate guidelines issued by nearly as many organizations over the previous 12 years.Technology Update: Redefining Echocardiography Diagnostics and Education with AI, AR, and Beyond
For a photographer or videographer, it’s second nature to use lighting to get a better view of a subject. But few cardiac imagers think about moving light sources within the heart.An Overview of Common Complications with Structural Heart Disease
The leading treatment option for AS and other structural diseases is transcatheter aortic valve replacement (TAVR). The overall complication rate of TAVR is relatively low -- around 4%. However, patients who experience complications have increased hospital lengths-of-stay and higher one-year mortality ratesPulmonary Arterial Hypertension and RV Failure
The average time from symptom onset to accurate diagnosis of pulmonary arterial hypertension (PAH) is 2.8 years, and more than half of patients have already progressed to functional class 3 or 4 by the time of diagnosis. Overlapping symptoms and clinical presentations can make it challenging to classify pulmonary hypertension patients correctly.REBIRTH Trial: Evaluating Bromocriptine Therapy for Peripartum Cardiomyopathy
In this presentation, Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor of Medicine at Lewis Katz School of Medicine at Temple University, outlines the REBIRTH Trial, a randomized trial that reviews the use of bromocriptine therapy for the treatment of peripartum cardiomyopathy (PPCM)Earlier Detection and Treatment of Advanced Heart Failure
In this presentation, Dr. Eman Hamad, Director, Advanced Heart Failure and Transplant Program at Temple University Hospital, shares best practice approaches to physician collaboration for better patient outcomes.Mechanical Circulatory Support Program
Recent advances in mechanical pump design and related care have dramatically improved the daily function, health, and quality of life for patients with debilitating heart failure.Referral Guidelines for Advanced Heart Failure Therapy
REFERRAL GUIDELINES FOR ADVANCED HEART FAILURE THERAPY: >2 PROMPT CONSULTATIONMultidisciplinary Group Approach to Managing Pregnant Patients with Cardiovascular Disease
Cardio obstetrics requires a multidisciplinary, patient-centered approach to managing heart failure and other cardiovascular issues in pregnant patients.Heart Failure with Preserved Ejection Fraction and Pregnancy
One of the most prevalent types of heart failure during pregnancy, heart failure with preserved ejection fraction and pregnancy (HFpEF), is associated with increased risk of hospitalization and adverse pregnancy outcomes.Heart Failure During Pregnancy
Heart failure is a complication in as many as 11% of pregnancies. However, normal cardiovascular changes during pregnancy can mimic heart failure symptoms, making it easy to misdiagnose.